Healios K.K.

Industry · 11 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome Trauma, Adult Stem Cells	Phase 2	2020-11-09
Unknown	MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) ARDS	Phase 2 / Phase 3	2020-04-28
Completed	Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome Respiratory Distress Syndrome, Adult	Phase 2	2019-01-01
Unknown	MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study Ischemic Stroke	Phase 3	2018-07-28
Completed	Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements Stroke, Acute	Phase 2 / Phase 3	2017-11-15
Completed	A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome Acute Respiratory Distress Syndrome	Phase 1 / Phase 2	2016-01-01
Terminated	A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction Heart Attack, NSTEMI	Phase 2	2015-12-01
Completed	Study to Examine the Effects of MultiStem in Ischemic Stroke Ischemic Stroke	Phase 2	2011-10-01
Withdrawn	A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety Obesity	Phase 2	2008-09-01
Completed	Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia Hematologic Malignancies	Phase 1	2008-07-01
Completed	Safety Study of AMI MultiStem® to Treat Heart Attacks Acute Myocardial Infarction	Phase 1	2008-05-01